MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02343nam a22002417a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20191010110314.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180715b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
MSA |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Relator code |
Nyera Hamdy Ibrahim 141797 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Pharmacokinetics and pharmacogenomics of cyclophosphamide in Rhabdomyosarcoma patients <br/>الحرائك الدوائية وعلم الأدوية الدوائي للسيكلوفوسفاميد في مرضى ساركومة العضلية // GP // DR.Rania Mohamed Labib // TA. Salma Wagih (2017-2018) |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Giza : |
| Name of publisher, distributor, etc. |
MSA |
| Date of publication, distribution, etc. |
2018 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
77 P. |
| Dimensions |
30 CM. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
PHARMACY DISTINGUISHED PROJECTS 2018 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Pharmacy-Clinical Pharmacy |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
renewing<br/>and asymmetric division that differentiate inside the body into<br/>for example , Somatic cells. Stem cell is possible to identify two large<br/>potential application fields of stem cells in diabetes mellitus: The<br/>reconstruction of β cell mass, and helps in the treatment of complications.<br/>Our target, find the mechanisms responsible for the effectiveness of bone<br/>marrow-derived mesnchymal stem cells in the suppression of DM Type 1.<br/>Experimental design: Eighteen male Albino Wistar rats divided into three<br/>groups , each Group having Six Rat Group I normal not diabetic and not<br/>suffering from any biochemical disorder, Group II Rats which are STZinduced<br/>diabetes group, Group III will be the Mesnchymal stem cells<br/>treated group MSCs (1×105 cells/rat) injected via tail veins in rats with<br/>STZ-induced diabetes. Blood glucose was measured spectrophotometry,<br/>Interleukin 6 and GLUT4 were measured by Elisa, insulin genes 1 and<br/>insulin genes 2 were measured by Real-time PCR. Insulin genes 1, insulin<br/>genes 2 and GLUT4 levels were significantly elevated in treated group<br/>compared to diabetic group (1). Interleukin 6 and blood glucose levels<br/>were significantly decreased in treated group compared to diabetic group.<br/>Mesnchymal stem cells may play an important role in treatment of T1DM |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacy |
| Form subdivision |
Clinical Pharmacy |
| General subdivision |
Pharmacokinetics & pharmacogenomics |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Loubna Mustafa Ibrahim 140507 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Merna Ashraf Milad 141481 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://drive.google.com/file/d/1o24AvopG1BwlN5R3_OkuKvHMAZ2irbWI/view?usp=sharing">https://drive.google.com/file/d/1o24AvopG1BwlN5R3_OkuKvHMAZ2irbWI/view?usp=sharing</a> |
| Public note |
FULL TEXT PRESS HERE |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Gradution Project |
